Corporate "Quantum Threshold": IBM Assesses Business Readiness for the New Era of Computing
While the market is spellbound by the qubit race, IBM suggests shifting the focus from abstract records to real business value. In its new report Journey to Quantum Advantage, the company redefines the very concept of "quantum advantage." This is not a universal finish line for everyone, but the ability to solve a specific problem—more accurately, faster, or cheaper than classical computers.
The Three Pillars of Quantum Motivation
The study, based on interviews with leaders from aerospace, finance, energy, and biomedicine, identified three main drivers for adopting quantum technologies. Topping the list is solving complex business problems (60% of respondents). This is followed by future-proofing computing strategy (55%) and accelerating innovation (54%).
However, the path to advantage is strewn with barriers. The main one is a catastrophic shortage of qualified personnel (61%). Next come technology immaturity (56%) and uncertainty about the timeline for practical scenarios (46%). As you can see, the problem lies not only in the "hardware" but also in the lack of people capable of working on it and formulating tasks.
Real-World Cases: From Aircraft to the Genome
The report shows that leading companies have already moved from theory to practice, albeit with caveats. Boeing sees quantum advantage in materials science and quantum chemistry for aircraft design. Vanguard has been experimenting with hybrid algorithms since 2022 to combat money laundering and optimize portfolios, emphasizing that advantage only makes sense in the context of client tasks.
Energy giant E.ON and industrial conglomerate Bosch have gone through the "valley of disappointment": early pilots on noisy devices revealed limitations in circuit depth and qubit connectivity. As a result, both companies have revised their roadmaps toward long-term preparation for fault-tolerant systems. This is an important signal: the market is learning from mistakes and not expecting an instant miracle.
The most promising results are in biomedicine. Yonsei University uses quantum resources in tandem with supercomputers to study mitochondrial processes, while the Quantum Pangenomics consortium has already loaded the complete genome of the hepatitis D virus onto a 156-qubit IBM Heron processor. Reducing drug development timelines by even 10-20% represents a colossal breakthrough.
The Ecosystem as a New Asset
IBM rightly notes that quantum readiness is not just about technology but also partnerships. One in two "quantum-ready" organizations participates in alliances of businesses, universities, and governments. Examples include Volkswagen, Bradesco, and Singapore.
My conclusion: The IBM report is a sobering yet necessary document for investors and technologists. It shatters the illusion that quantum supremacy is "just around the corner." In reality, we are witnessing a period of mature experimentation, where the winner is not the one with more qubits, but the one who knows how to ask the right questions and build bridges between quantum physics and business metrics.